108
7
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10480 | Bay 41-4109 (less active enantiomer) | HBV | Microbiology/Virology |
Bay 41-4109 less active enantiomer shows less activity than Bay 41-4109. BAY 41-4109 is a potent HBV inhibitor (IC50: 53 nM). | |||
T6352 |
(-)-Dizocilpine maleate
C13737,(-)-MK 801 (Maleate),(-)-MK 801马来酸,(-)-MK 801 Maleate |
NMDAR; iGluR | Membrane transporter/Ion channel; Neuroscience |
(-)-Dizocilpine maleate ((-)-MK 801 (Maleate)) 是一种选择性且非竞争性的 N-甲基-D-天冬氨酸 (NMDA) 受体拮抗剂,Ki 为 211.7 nM。它是一种 Dizocilpine 的活性较低的 (-)-对映体,具有抗抑郁作用。 | |||
T12814 |
(S)-Tenofovir
(S)-替诺福韦,(S)-PMPA,(S)-GS 1278,(S)-TDF |
Others | Others |
(S)-Tenofovir ((S)-PMPA) 是Tenofovir 的活性较低的S-对映体,Tenofovir 是一种核苷酸逆转录酶抑制剂。 | |||
T12664 |
(Rac)-BRD0705
|
Others | Others |
(Rac)-BRD0705 是 BRD0705 的活性较低的外消旋体。 BRD0705 是一种有效的特异性 GSK3α 抑制剂。 | |||
T12831 |
SAR405 R enantiomer
|
Others | Others |
SAR405 R enantiomer 是一种 PIK3C3/Vps34 抑制剂,也是活性低于 SAR405 的对映体。 | |||
T68051L |
RS 15385-198
|
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
RS 15385-198 是 Delequamine 的低活性异构体。Delequamine 是一种选择性 α2-肾上腺素受体拮抗剂。 | |||
T10376 |
ARS-1630
|
Ras | GPCR/G Protein; MAPK |
ARS-1630 是一种突变型 K-ras G12C 抑制剂。 它是 ARS-1620 的活性较低的对映异构体。 | |||
T7080 |
CCT245737
SRA737 |
Chk | Cell Cycle/Checkpoint |
CCT245737 (SRA737) 是一种具有口服活性的选择性 Chk1 抑制剂,IC50值为 1.3 nM。 | |||
T9554 |
SN-008
|
STING | Immunology/Inflammation |
SN-008 是 SN-011 的低活性类似物,可作为阴性对照。 | |||
T11129L |
Duvelisib (R enantiomer) hydrochloride
IPI-145 R enantiomer HCl,Duvelisib (R enantiomer) hydrochloride(1261590-48-0 Free base),INK1197 R enantiomer HCl |
PI3K | PI3K/Akt/mTOR signaling |
Duvelisib (R enantiomer) hydrochloride (INK1197 R enantiomer HCl) 是 PI3K 抑制剂。Duvelisib (R enantiomer) hydrochloride 是 Duvelisib 的活性较低的对映体。 | |||
T22450 |
Tyrphostin B44, (+) enantiomer
酪氨酸磷酸化抑制剂AG 835 |
EGFR | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
Tyrphostin B44, (+) enantiomer 是一种表皮生长因子受体 (EGFR) 激酶抑制剂,IC50 为 0.86 μM,活性低于 (-) 对映体。 | |||
T6205 |
AT7519
|
Apoptosis; GSK-3; CDK | Apoptosis; Cell Cycle/Checkpoint; PI3K/Akt/mTOR signaling; Stem Cells |
AT7519 是一种CDK 抑制剂,对 CDK1,CDK2,CDK4-CDK6 以及 CDK9 的IC50值分别为 210,47,100,13,170 和 <10 nM。 | |||
T22818 |
GSK9027
GR agonist 23a,GSK 9027,GSK-9027 |
Glucocorticoid Receptor | Endocrinology/Hormones |
GSK9027 (GR agonist 23a) 是一种非甾体糖皮质激素受体 (GR) 激动剂。GSK9027 (GR agonist 23a) 在2×GRE报告基因上对比地塞米松的活性属于部分激动剂,活性较地塞米松活性较弱。 | |||
T9042 |
Teriflunomide impurity 3
4-Amino-N-(4-trifluoromethylphenyl)benzamide |
COX | Immunology/Inflammation; Neuroscience |
Teriflunomide impurity 3 (4-Amino-N-(4-trifluoromethylphenyl)benzamide) 是一种选择性COX-1抑制剂,IC50为 30 µM。 | |||
T16759 |
Ritanserin
利坦丝林,R 55667 |
Dopamine Receptor; 5-HT Receptor; Adrenergic Receptor; Histamine Receptor | GPCR/G Protein; Immunology/Inflammation; Neuroscience |
Ritanserin (R 55667) 是一种长效、高效、相对选择性、可口服的5-HT2受体拮抗剂,IC50值为 0.9 nM。 | |||
T67905 |
GS-829845
|
JAK; Drug Metabolite | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Metabolism; Stem Cells |
GS-829845 是一种 JAK1 抑制剂,是 Filgotinib 活性代谢物的主要成分,其效力比母体低约 10 倍且半衰期更长。 | |||
T12146 |
N-Desmethyl-Apalutamide
N-Desmethyl Apalutamide,N-去甲基阿帕鲁胺杂质 |
P450; Androgen Receptor | Endocrinology/Hormones; Metabolism |
N-Desmethyl-Apalutamide 是一种 Apalutamide 的活性代谢产物,主要由 CYP2C8 和 CYP3A4 介导形成。它是一种低活性的雄激素受体拮抗剂,其作用力是 Apalutamide 活性的三分之一。它是中等至强的CYP3A4和CYP2B6诱导剂,并具有优异的血浆蛋白结合浓度。 | |||
T6104 |
Cerdulatinib hydrochloride
Cerdulatinib,PRT2070,PRT062070 hydrochloride,PRT062070,PRT2070 hydrochloride |
MLK; c-Fms; Tyrosine Kinases; Hippo pathway; JAK; Syk | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; Stem Cells; Tyrosine Kinase/Adaptors |
Cerdulatinib hydrochloride (PRT2070 hydrochloride) 是一种选择性可逆,具有口服活性、 ATP 竞争性的 SYK 和 JAK 的双重抑制剂,抑制 JAK1、2、3、SYK 和 Tyk2的 IC50值分别为12、6、8、32 和 0.5 nM。它可用于研究自身免疫性疾病和B 细胞恶性肿瘤。 | |||
T15545 |
ICA-27243
|
Potassium Channel | Membrane transporter/Ion channel |
ICA-27243 是选择性的,口服有效的 KCNQ2/Q3钾通道开放剂,EC50为 0.38 μM。对 KCNQ4 和 KCNQ3/Q5 的激活效果较差。它具有抗惊厥和抗癫痫作用。 | |||
T12695 |
RBN-2397
|
PARP | Chromatin/Epigenetic; DNA Damage/DNA Repair |
RBN-2397 是一种有效的、选择性的、具有口服活性的跨物种 NAD+ 竞争性 PARP7 抑制剂,IC50 小于 3 nM。它选择性结合 PARP7 ,Kd 为0.001 μM,可恢复干扰素 I 型信号转导,有用于晚期或转移性实体肿瘤的研究潜力。 | |||
T21938 |
AS-041164
|
PI3K | PI3K/Akt/mTOR signaling |
AS-041164 是选择性的,具有口服活性的PI3Kγ亚型抑制剂,IC50=70 nM。它对 PI3Kα (IC50:240 μM),PI3Kβ (IC50:1.45 μM) 和 PI3Kδ (IC50:1.70 μM) 的活性较低。它具有抗炎活性。 | |||
T4481 |
Tucidinostat
HBI-8000,Chidamide,西达本胺,CS 055 |
HDAC | Chromatin/Epigenetic; DNA Damage/DNA Repair |
Tucidinostat (Chidamide) 是一种可口服的 HDAC I 类 HDAC1/2/3和第 IIb 类 HDAC10的抑制剂,IC50值分别为 95、160、67 和 78 nM。 | |||
T6458 |
CYC-116
噻氯匹定 |
VEGFR; FLT; CDK; S6 Kinase; Aurora Kinase | Angiogenesis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
CYC116是一种有效的极光激酶 A 和 B 的抑制剂,Ki 值分别为8和9 nM。 | |||
T13140 |
Umbralisib R-enantiomer
TGR-1202 R-enantiomer,RP5264 R-enantiomer |
PI3K | PI3K/Akt/mTOR signaling |
Umbralisib R-enantiomer (RP5264 R-enantiomer) 是 PI3K 的δ型抑制剂,是 TGR-1202 活性较低的对映体。Umbralisib R-enantiomer 对δ型 pi3激酶的 IC50,至少比抑制剂对其他 PI3K 亚型(A, β和γ)的 IC50低20倍。 | |||
T11991 |
Mefentrifluconazole
|
P450; Antifungal | Metabolism; Microbiology/Virology |
Mefentrifluconazole 是一种有效的、选择性的和具有口服活性的真菌 CYP51 (Kd= 0.5 nM) 抑制剂,但对人芳香酶的抑制活性较低,IC50值为0.92 μM。它是一种新型唑类衍生物,用作农用广谱抗真菌剂。 | |||
T0932 |
Cefixime
FK-027,头孢克肟,Cefspan,Cefiximum,Cephoral,FR-17027,CL-284635 |
Antibacterial; Antibiotic | Microbiology/Virology |
Cefixime (FR-17027) 是一种头孢菌素类抗生素, 可研究一些细菌感染。 | |||
T20898 |
(R)-Propranolol hydrochloride
Dexpropranolol hydrochloride,(R)-(+)-Propranolol,盐酸普奈洛尔 |
Adrenergic Receptor | GPCR/G Protein; Neuroscience |
(R)-Propranolol hydrochloride (Dexpropranolol hydrochloride) 是一种抗肾上腺素受体拮抗剂,是一种普萘洛尔的活性较低的对映体。Dexpropranolol 是一种非选择性的β-adrenergic receptor 拮抗剂,对 β1AR 和 β2AR 具有高亲和力。 | |||
T35528L |
TD52 dihydrochloride
TD52 dihydrochloride(1798328-24-1 Free base),TD52 2HCl |
Others | Others |
TD52 dihydrochloride (TD52 2HCl), a derivative of Erlotinib, is a potent and orally active inhibitor of protein phosphatase 2A (CIP2A). It exhibits strong anti-cancer properties by regulating the CIP2A/PP2A/p-Akt signaling pathway, resulting in the induction of apoptosis in triple-negative breast cancer (TNBC) cells. Mechanistically, TD52 dihydrochloride disrupts the binding of Elk1 to the CIP2A promoter, effectively reducing CIP2A levels. Notably, TD52 dihydrochloride demonstrates powerful anti... | |||
T15199 |
Edicotinib
JNJ-527,JNJ-40346527 |
c-Fms; FLT; CSF-1R; c-Kit | Angiogenesis; Tyrosine Kinase/Adaptors |
Edicotinib (JNJ-527) 是能够透过血脑屏障的、口服具有活性的、选择性的CSF-1R 抑制剂 (IC50:3.2 nM)。它对 KIT (IC50:20 nM) 和 FLT3 (IC50:190 nM) 的抑制作用较小。它抑制小胶质细胞的扩张,减弱小胶质细胞的增殖和神经退行性变。它可用于研究阿尔茨海默病和类风湿性关节炎。 | |||
T6446 |
Clevudine
L-FMAU,克拉夫定,Levovir |
HBV; DNA/RNA Synthesis | Cell Cycle/Checkpoint; DNA Damage/DNA Repair; Microbiology/Virology |
Clevudine (Levovir) 是一种非自然 L-构型的核苷类似物,是一种与聚合酶结合的非竞争性抑制剂,具有较强的抗 HBV 活性,半衰期长,毒性低的特点。 | |||
T60336 |
CCR4 antagonist 3-1
|
CCR | Immunology/Inflammation; Microbiology/Virology |
CCR4 antagonist 3-1 是一种具有较低活性的趋化因子受体 4 (CCR4) 拮抗剂,对 [125I]TARC (胸腺和活化调节趋化因子) 具有抑制作用,IC50 值为 1.7 μM。CCR4 antagonist 3-1 对放射标记的[125I]TARC和巨噬细胞来源的趋化因子(MDC) 与 CEM 细胞表面的CCR4 受体的结合有抑制作用, 并对 TARC 介导的 CEM 细胞的体外迁移有抑制作用,IC50 值为 6.4 μM。 | |||
T13438 |
(R,S)-Ivosidenib
(R,S)-AG-120 |
Opioid Receptor | Endocrinology/Hormones; GPCR/G Protein; Neuroscience |
(R,S)-Ivosidenib is the less active enantiomer of Ivosidenib . | |||
T13450 | (S)-GNE-140 | Others | Others |
(S)-GNE-140 is the less active enantiomer of GNE-140. | |||
T13426L |
(3S,4S)-Tofacitinib
(3S,4S)-托法替尼 |
Others | Others |
(3S,4S)-Tofacitinib, a less active enantiomer of tofacitinib, is a Janus kinases inhibitor. | |||
T13451 |
(S)-Mapracorat
(S)-ZK-245186,(S)-BOL-303242X |
Others | Others |
(S)-Mapracorat is a selective and less active agonist of glucocorticoid receptor. | |||
T26371 |
(2S,3R)-LP99
|
||
(2S,3R)-LP99 is a less active enantiomer of LP99. | |||
T11801 |
l-Atabrine dihydrochloride
|
Others | Others |
l-Atabrine dihydrochloride displays antiprion activity. l-Atabrine dihydrochloride is a less active enantiomer of quinacrine. | |||
T26163 |
Rubradirin B
|
||
Rubradirin B has an antibacterial activity similar to rubradirin, but the antibiotic is less active. | |||
T10564 |
(8R,9S)-Talazoparib
(8R,9S)-BMN-673,他拉唑帕利 (8R,9S) |
Others | Others |
(8R,9S)-Talazoparib is Talazoparib enantiomer , less active than Talazoparib on the inhibition of PARP1 (IC50: 144 nM). | |||
T19549 | Ro18-5362 | Others | Others |
Ro18-5362 is the less active prodrug of Ro 18-5364. | |||
T12635 |
(R)-Plevitrexed
(R)-ZD 9331,(R)-BGC9331,(R)-普来曲塞 |
Others | Others |
(R)-Plevitrexed is a less active enantiomer of Plevitrexed. Plevitrexed is an orally active and potent inhibitor of thymidylate synthase (TS). | |||
T11156 |
Nazartinib S-enantiomer
EGF816 (S-enantiomer) |
Others | Others |
Nazartinib is an EGFR inhibitor. Nazartinib S-enantiomer is the less active S-enantiomer of Nazartinib. | |||
T10856 |
Cobimetinib (R-enantiomer)
考比替尼 (R 型对映体),XL-518 R-enantiomer,Cobimetinib R-enantiomer,GDC-0973 R-enantiomer |
Others | Others |
Cobimetinib R-enantiomer is the less active R-enantiomer of Cobimetinib which is a selective MEK inhibitor. | |||
T12636 |
(R)-(+)-Anatabine
|
Others | Others |
(R)-(+)-Anatabine is an less active R-enantiomer of Anatabine. Anatabine is a potent agonist of α4β2 nAChR. | |||
T6493L |
(R)-Citalopram oxalate
|
||
(R)-Citalopram oxalate is a less active enantiomer of Escitalopram Oxalate. Escitalopram Oxalate is a potent and selective serotonin reuptake inhibitor. | |||
T13427 |
(3S,4R)-Tofacitinib
|
Others | Others |
(3S,4R)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM). | |||
T13426 | (3R,4S)-Tofacitinib | Others | Others |
(3R,4S)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM). | |||
T11334 |
Fulvestrant (R enantiomer)
ICI 182780 R enantiomer,ZD 9238 R enantiomer,ZM 182780 R enantiomer,Fulvestrant R enantiomer |
Others | Others |
Fulvestrant R enantiomer is the less active R enantiomer of Fulvestrant. Fulvestrant is a potent estrogen receptor antagonist with an IC50 of 9.4 nM. | |||
T11335 |
Fulvestrant (S enantiomer)
ZM 182780 S enantiomer,ICI 182780 S enantiomer,Fulvestrant S enantiomer,ZD 9238 S enantiomer |
Others | Others |
Fulvestrant S enantiomer is the less active S enantiomer of Fulvestrant. Fulvestrant is a potent estrogen receptor antagonist with an IC50 of 9.4 nM. | |||
T12641 |
(R)-SCH 42495
|
Others | Others |
(R)-SCH 42495 is the less active enantiomer of SCH 42495. SCH 42495 is an orally active inhibitor of neutral metalloendopeptidase (NEP), with antihypertensive effect. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T20191 |
(-)-Camphoric acid
(-)-樟脑酸,L-Camphoric acid,Camphoric acid, (-)- |
GluR | Neuroscience |
(-)-Camphoric acid (L-Camphoric acid) 是一种活性较低的樟脑酸对映异构体,樟脑酸可诱导 GluR 表达。 | |||
T13669 |
(E)-Cinnamamide
trans-Cinnamamide,肉桂酰胺 |
Others | Others |
(E)-Cinnamamide (trans-Cinnamamide) 是 Cinnamamide 的活性较低的异构体,Cinnamamide 是一种有效的非致命化学驱虫剂,适用于减少鸟类害虫的损害。 | |||
TN1448 |
(-)-Bornyl acetate
L-(-)-Bornyl acetate,左旋乙酸冰片酯,Bornyl acetate,(-)-乙酸龙脑酯 |
p38 MAPK; NF-κB; JNK; Antifungal | MAPK; Microbiology/Virology; NF-κB |
(-)-Bornyl acetate (L-(-)-Bornyl acetate) 是存在于牛膝草油中的一种具有抗真菌活性的 (+)-Bornyl acetate 低活性异构体。 | |||
T36585 |
Isodeoxycholic Acid
isoDCA |
Chloride channel; Antibacterial | Membrane transporter/Ion channel; Microbiology/Virology |
Isodeoxycholic Acid 是一种胆汁酸,由肠道细菌通过脱氧胆酸的表聚作用形成。Isodeoxycholic acid 的临界胶束浓度高于二氯苯甲醚,这表明它的去污活性降低了,而且在抑制七种肠道共生细菌生长方面的活性低于二氯苯甲醚。Isodeoxycholic Acid(0.1%)能抑制几种艰难梭菌菌株在牛磺胆酸诱导下的孢子萌发,并能降低艰难梭菌培养上清对 Vero 细胞的细胞毒性。在高脂饮食诱发肥胖的大鼠模型中,血浆中的Isodeoxycholic acid 水平比正常饮食的大鼠低。 | |||
TN2931 |
3-Epikatonic acid
|
Antifection | Microbiology/Virology |
Epikatonic acid shows less active against T. (S.) cruzi trypanosome. | |||
T38497 |
(-)-Taxifolin
(-)-二氢槲皮素,(-)-Dihydroquercetin |
||
(-)-Taxifolin is the less active enantiomer of Taxifolin, demonstrating vital anti-tyrosinase activity and notable inhibition against collagenase (IC50 = 193.3 μM). It is valued as an essential natural compound showing antifibrotic potential, while also acting as a capable free radical scavenger and possessing antioxidant capacity. | |||
TN4471 |
Lysicamine
|
IL Receptor; Antifection | Immunology/Inflammation; Microbiology/Virology |
Lysicamine shows significant antioxidant capacity in the ORAC(FL) assay and it is active against S. epidermidis and C. dubliniensis, with MIC values in the range 12.5-100 microg mL(-1). Lysicamine has antimicrobial and anti-inflammation activity, the mini |